Business Wire

Lovenox: 2018 Drug Insights - Product Details on the Basis of MOA, Target, Dosage, Route of Administration, Molecule Type, Strength, Chemical Type and ATC Classification ...

DUBLIN--(BUSINESS WIRE)--The "Lovenox - Drug Insight, 2018" drug pipelines has been added to ResearchAndMarkets.com's offering. 'Lovenox Drug Insight, 2018' highlights the drug marketed details and ...
Medscape

FDA Safety Labeling Changes: Lovenox, Nutropin Depot, Roferon-A

Dec. 22, 2004 — The U.S. Food and Drug Administration (FDA) approved in October revisions to drug safety labeling to advise healthcare professionals of the following changes: use of the multidose ...
Medscape

Reduced Enoxaparin Dose Required in Severe Renal Impairment

Aug. 18, 2004 — The U.S. Food and Drug Administration (FDA) and Aventis Pharmaceuticals notified healthcare professionals in March of revisions to the precautions section of drug labeling for ...
Reuters

Sanofi loses U.S. Lovenox patent case

PARIS, Feb 9 (Reuters) - French drugs group Sanofi-Aventis said on Friday a California court had ruled against it in a case pitting it against Amphastar and Teva over the best-selling Lovenox drug.